Bank of New York Mellon
AKYA

Bank of New York Mellon’s Akoya BioSciences AKYA Stock Holding History

Bank of New York Mellon’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-45,220
Closed -$62.9K – 4142
2025
Q1 		$62.9K Sell
45,220
-5,445
-11% -$11.9K ﹤0.01% 4039
2024
Q4 		$116K Sell
50,665
-5,717
-10% -$15.1K ﹤0.01% 4020
2024
Q3 		$153K Sell
56,382
-11,086
-16% -$27.1K ﹤0.01% 3959
2024
Q2 		$158K Buy
67,468
+9,429
+16% +$30.1K ﹤0.01% 3984
2024
Q1 		$272K Sell
58,039
-26,791
-32% -$139K ﹤0.01% 3817
2023
Q4 		$414K Sell
84,830
-48,004
-36% -$199K ﹤0.01% 3661
2023
Q3 		$618K Buy
132,834
+10,233
+8% +$58.8K ﹤0.01% 3434
2023
Q2 		$906K Buy
122,601
+52,372
+75% +$350K ﹤0.01% 3251
2023
Q1 		$574K Sell
70,229
-1,333
-2% -$13.9K ﹤0.01% 3426
2022
Q4 		$685K Sell
71,562
-4,275
-6% -$52.6K ﹤0.01% 3384
2022
Q3 		$891K Buy
75,837
+10,547
+16% +$139K ﹤0.01% 3264
2022
Q2 		$838K Buy
65,290
+18,747
+40% +$194K ﹤0.01% 3303
2022
Q1 		$511K Buy
46,543
+9,027
+24% +$105K ﹤0.01% 3693
2021
Q4 		$574K Buy
37,516
+11,236
+43% +$147K ﹤0.01% 3714
2021
Q3 		$367K Buy
26,280
+13,042
+99% +$218K ﹤0.01% 3963
2021
Q2 		$256K Buy
+13,238
New +$273K ﹤0.01% 4015

Other funds holding AKYA

BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PCA
Peddock Capital Advisors Braintree, Massachusetts $501M AUM 29.8% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Bank of New York Mellon's AKYA Position: Q2 2025 in Review

Bank of New York Mellon sold out of Akoya BioSciences (AKYA) in Q2 2025, closing a stake of 45,220 shares — an estimated $62.9K sold.

Bank of New York Mellon first reported a position in AKYA in Q2 2021 and held it in 16 quarters. The position peaked at $906K in Q2 2023. 58 funds tracked by Wall St. Rank hold AKYA as of Q2 2025.

  • Bank of New York Mellon reported no remaining Akoya BioSciences position as of Q2 2025 after selling out during the quarter.
  • Bank of New York Mellon sold 45,220 Akoya BioSciences shares in Q2 2025, an estimated $62.9K.
  • Bank of New York Mellon first reported a position in Akoya BioSciences in Q2 2021 and held it in 16 quarters.
  • Bank of New York Mellon's Akoya BioSciences position peaked at $906K in Q2 2023.
  • 58 funds tracked by Wall St. Rank held Akoya BioSciences as of Q2 2025.

Based on Bank of New York Mellon's 13F filing for Q2 2025, filed 5 Aug 2025.